valproic acid has been researched along with angiotensin ii in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Georgiev, VP; Kambourova, TS; Lazarova, MB | 1 |
| Chiodera, P; Coiro, V | 2 |
| Lu, Y; Yang, S | 1 |
| Dargatz, H; Fahr, A; Heinzel, T; Hennig, D; Imhof, D; Kostenis, E; Schubert, S; Schubert, US | 1 |
| Choi, J; Kim, JI; Kwon, TK; Park, KM; Park, S; Sohn, SI | 1 |
1 trial(s) available for valproic acid and angiotensin ii
| Article | Year |
|---|---|
Inhibition by sodium valproate of the arginine vasopressin and adrenocorticotropin responses to angiotensin II in normal men.
Topics: 4-Aminobutyrate Transaminase; Adrenocorticotropic Hormone; Adult; Angiotensin II; Arginine Vasopressin; Enzyme Inhibitors; gamma-Aminobutyric Acid; Humans; Male; Valproic Acid | 1989 |
6 other study(ies) available for valproic acid and angiotensin ii
| Article | Year |
|---|---|
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Interactions between angiotensin II, diazepam, clonazepam and di-n-propylacetate in pentylenetetrazol kindling seizures in mice.
Topics: Angiotensin II; Animals; Clonazepam; Diazepam; Drug Interactions; Electric Stimulation; Ionophores; Kindling, Neurologic; Male; Pentylenetetrazole; Rats; Rats, Inbred Strains; Receptors, GABA-A; Seizures; Valproic Acid | 1991 |
Different effects of the GABAergic agent sodium valproate on the oxytocin responses to angiotensin II and insulin-induced hypoglycemia in normal men.
Topics: Adult; Angiotensin II; Blood Glucose; Humans; Hypoglycemia; Insulin; Male; Oxytocin; Valproic Acid | 1991 |
Angiotensin II induces cardiomyocyte hypertrophy probably through histone deacetylases.
Topics: Angiotensin II; Animals; Animals, Newborn; Cell Enlargement; Cell Size; Cells, Cultured; Gene Expression; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Hypertrophy; Myocytes, Cardiac; Myosin Heavy Chains; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Valproic Acid | 2009 |
Novel insights into appropriate encapsulation methods for bioactive compounds into polymers: a study with peptides and HDAC inhibitors.
Topics: Acetylation; Angiotensin II; Carbazoles; Dextrans; Drug Carriers; HEK293 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lactic Acid; Liposomes; Nanoparticles; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sirtuin 1; Valproic Acid | 2014 |
Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via inhibition of HDAC1/angiotensin II axis.
Topics: Angiotensin II; Animals; Blotting, Western; Diet, High-Fat; Disease Models, Animal; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Hypertension; Male; Mice; Mice, Inbred C57BL; Valproic Acid | 2017 |